PI-2301
Merck licences new MS drug
September 19, 2011Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301
Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
